Articles From: Capstone Turbine Announces Common Stock Offering to BioMed Realty Brings Intertek Pharmaceutical Services To Wateridge Summit: San Diego Project Now 96% Leased


CHATSWORTH, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- Capstone Turbine Corporation (Nasdaq:CPST) (the "Company") today announced that it has entered into an underwriting agreement to sell 18,825,000 shares of its common stock at a price to the public of $1.70 per share for gross proceeds of approximately $32.0 million.
Sign-up for Capstone Turbine Announces Common Stock Offering investment picks
ROCHESTER, N.Y. , May 1, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP) , a leading provider of quantitative imaging solutions, today announced it will report its first quarter 2014 financial results before the market opens on Thursday, May 15 , 2014.
Sign-up for VirtualScopics, Inc. Schedules First Quarter 2014 Financial Results Press Release And Conference Call investment picks
RADNOR, Pa., May 1, 2014 (GLOBE NEWSWIRE) -- ICG Group, Inc. (Nasdaq:ICGE) ("ICG") today reported its results for the first quarter ended March 31, 2014.
Sign-up for ICG Announces First Quarter 2014 Financial Results investment picks
SAN DIEGO, May 1, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that its Chief Financial Officer, Graham Cooper, will be presenting at the Deutsche Bank Securities Annual Healthcare Conference at the InterContinental Hotel in Boston.
Sign-up for Receptos to Present at Deutsche Bank Securities Annual Healthcare Conference investment picks
Agilysys, Inc. (Nasdaq:AGYS) , a leading developer and provider of innovative information technology and hospitality software solutions and services, announced today that it will release its fiscal 2014 fourth quarter and year end results after the market closes on Wednesday, May 14, 2014 and will host a conference call and webcast at 4:30 p.m. ET on Wednesday, May 14.
Sign-up for Agilysys to Report Fiscal 2014 Fourth Quarter and Year End Results on May 14 and Host Conference Call and Webcast investment picks
CHICAGO, May 1, 2014 (GLOBE NEWSWIRE) -- Durata Therapeutics, Inc. (Nasdaq:DRTX) has scheduled its quarterly conference call for Thursday, May 8 at 8:30 a.m. Eastern Time to discuss first quarter 2014 financial results.
Sign-up for Durata Therapeutics to Announce First Quarter 2014 Financial Results on May 8, 2014 investment picks
NEW YORK , April 30, 2014 /PRNewswire/ -- Weight Watchers International, Inc. (NYSE: WTW) today announced its results for the first quarter of fiscal 2014 and raised its full year fiscal 2014 earnings guidance.
Sign-up for Weight Watchers Announces First Quarter 2014 Results And Raises Its Fiscal 2014 Earnings Guidance investment picks
LONDON (MarketWatch) -- Motorola Solutions Inc. (MSI) on Thursday said first-quarter net earnings were $127 million, or 49 cents a share, compared with $192 million, or 68 cents a share, in the same quarter last year.
Sign-up for Motorola Solutions profit, sales drop; projects revenue decline investment picks
Contract with PTT-MCC Biochem, a joint venture between Mitsubishi Chemical and PTT PCL Contract guarantees sales volume for Sarnia plant during its first three years of operation Agreement ensures BioAmber is the principal supplier to a key emerging buyer of succinic acid PTTMCC selection of BioAmber as supplier validates bio-succinic cost competitiveness and quality MINNEAPOLIS, MN , May 1, 2014 /CNW/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced it has signed its first take-or-pay contract for succinic acid.
Sign-up for BioAmber Signs Its First Succinic Acid Take-or-Pay Contract investment picks
CRANBURY, N.J. , May 1, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that a potential commercial partner has exercised its option for an exclusive license to bremelanotide for female sexual dysfunction (FSD) indications in the European Union and other European countries.
Sign-up for Palatin Technologies Announces Option Exercise by Specialty Pharmaceutical Company to License Bremelanotide in Europe investment picks
- Colder than normal weather increases usage - Continued robust customer growth - Enable Midstream IPO complete HOUSTON , May 1, 2014 /PRNewswire/ -- CenterPoint Energy, Inc. (NYSE: CNP) today reported net income of $185 million , or $0.43 per diluted share, for the first quarter of 2014, compared to $147 million , or $0.34 per diluted share the previous year.
Sign-up for CenterPoint Energy reports first quarter 2014 earnings; Increases full year guidance investment picks
http://media.marketwire.com/attachments/201103/50690_QuantumLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112573&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Quantum Corporation Reports Fiscal Fourth Quarter and Full Year 2014 Results investment picks
PHILADELPHIA , May 13, 2014 /PRNewswire/ -- Crown Cork & Seal USA , Inc., an affiliate of Crown Holdings, Inc. (NYSE: CCK) (Crown) ( www.crowncork.com ), has successfully reached a new, multi-year labor agreement with United Steelworkers (USW) Local Union 87-3.
Sign-up for New Labor Agreement With United Steelworkers Reached At Crown's Toledo Food Packaging Facility investment picks
New Flexible Production Line at Existing Chesterfield, Va., Site to Produce Polymer for Packaging Film, Other Applications MORRIS TOWNSHIP, N.J. , April 29, 2014 /PRNewswire/ -- Honeywell (NYSE: HON) Resins and Chemicals announced today that it will expand production capacity at its Chesterfield, Va.
Sign-up for Honeywell Resins and Chemicals To Expand Nylon Polymer Production Capacity investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0942074001&sourceType=1 http://www.ccnmatthews.com/logos/20110920-FINNING%20LARGE.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Finning to Announce Q1 2014 Results and Hold Annual General Meeting on May 13, 2014; Investor Call on May 14, 2014 investment picks
Live Webcasts from Las Vegas on May 15th and New York on May 20th SAN DIEGO , May 8, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP) , an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P.
Sign-up for MEI Pharma to Present at Bank of America Merrill Lynch and UBS Healthcare Conferences investment picks
- Dosing Initiated in Phase 1 Study to Evaluate the Safety, Tolerability and Antiviral Activity of ACH-3422, NS5B Uridine-Analog Nucleotide Prodrug - NEW HAVEN, Conn., April 30, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that is has begun dosing study participants with ACH-3422, Achillion's proprietary uridine-analog nucleotide inhibitor, in a Phase 1 clinical trial.
Sign-up for Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, for HCV investment picks
NEW YORK (MarketWatch) -- Shares of Sallie Mae (SLM) fell about 20% in premarket trade Thursday, after the spinoff of its loan-management, servicing and asset-recovery business.
Sign-up for Sallie Mae shares fall following spinoff of loan management business investment picks
ATHENS, Greece , May 12, 2014 /PRNewswire/ -- Paragon Shipping Inc. (NASDAQ: PRGN) ("Paragon Shipping" or the "Company"), a global shipping transportation company specializing in drybulk cargoes, announced today that it will release its results for the first quarter ended March 31, 2014 , after the market closes in New York on Monday, May 19, 2014 .
Sign-up for Paragon Shipping Announces Date For The Release Of First Quarter 2014 Results, Conference Call And Webcast investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
Achieved Primary Endpoint of Complete Response (CR) in the Delayed Period (24 to 120 Hours) Following Initiation of Chemotherapy Achieved Key Secondary Endpoints of CR in the Acute and Overall Periods Achieved All Secondary Endpoints, Including No Significant Nausea Adverse Event Profile Consistent with Earlier Clinical Trials New Drug Application (NDA) Submission to U.S. FDA On Track for Mid-2014 WALTHAM, Mass., May 12, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). The rolapitant arm in this trial, which enrolled patients receiving cisplatin-based, highly emetogenic chemotherapy (HEC), successfully achieved statistical significance over the standard
Sign-up for TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant investment picks
The world's smallest 5-mode LTE Advanced Carrier Aggregation modem, the Ericsson M7450, is fully tested and certified by China Mobile First devices integrating the Ericsson M7450 will be on the market in the second half of this year STOCKHOLM, Sweden, May 12, 2014 (GLOBE NEWSWIRE) -- Ericsson (NASDAQ: ERIC) today announced that the M7450 5-mode modem chipset, covering all five access technologies (TD-LTE, LTE FDD, WCDMA, TD-SCDMA and GSM), has been fully tested and certified for use in China Mobile's network.
Sign-up for China Mobile certifies Ericsson's LTE advanced modem investment picks
SAN DIEGO and WASHINGTON, April 30, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Pepco Holdings, Inc. (NYSE: POM) by Exelon Corporation (NYSE: EXC) .
Sign-up for Acquisition of Pepco Holdings, Inc. by Exelon Corporation May Not Be in Shareholders' Best Interests investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0942878001&sourceType=1 http://www.ccnmatthews.com/logos/20080605-TKLOGO2.JPG HAMILTON, BERMUDA --
Sign-up for Teekay Offshore Partners Announces First Quarter 2014 Earnings Results Conference Call investment picks
BEIJING , May 1, 2014 /PRNewswire/ -- Bitauto Holdings Limited ("Bitauto" or the "Company") (NYSE: BITA) , a leading provider of Internet content and marketing services for China's fast-growing automotive industry, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2014 , before the U.S. market opens on Thursday, May 8, 2014 .
Sign-up for Bitauto to Report First Quarter Unaudited Financial Results on Thursday, May 8, 2014 investment picks
OMAHA, Neb.
Sign-up for Bansal to Become Valmont COO investment picks
Report details outcomes for 2U-enabled degree programs LANDOVER, Md.
Sign-up for 2U, Inc. Releases First Online Higher Education "Impact Report" investment picks
Intertek Signs 46,142 SF Long-Term Lease to Join Inovio Pharmaceuticals and Genalyte as New Tenants at the Sorrento Valley Property since April 2013 SAN DIEGO , May 8, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of a new long-term lease with Intertek USA , Inc., a division of Intertek Group plc (LSE: ITRK), for 46,142 square feet at the company's Wateridge Summit property in San Diego, California .
Sign-up for BioMed Realty Brings Intertek Pharmaceutical Services To Wateridge Summit: San Diego Project Now 96% Leased investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Capstone Turbine Announces Common Stock Offering to BioMed Realty Brings Intertek Pharmaceutical Services To Wateridge Summit: San Diego Project Now 96% Leased
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry